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Hydroxyl radical mediation of immune renal injury by desfer-
rioxamine. The acute phase of glomerular injury in a model of anti-
glomerular basement membrane, antibody—induced glomerulonephritis
(antiGBM-GN) in rabbits was shown to be neutrophil—dependent using
nitrogen mustard depletion studies. Administration of desferrioxamine
(DFX) prevented the development of proteinuria in this model of renal
injury [24 hr protein excretion (mean SaM): antiGBM-GN/DFX =
16.2 2.9mg compared with antiGBM-GN control = 271.5 92.2 mg,
P < 0.01]. Antibody binding levels, glomerular filtration rates, circu-
lating complement and neutrophil counts, glomerular C3 deposition,
and neutrophil infiltration did not differ between DFX treated and
antiGBM-GN groups. In vitro assay systems to assess oxygen radical
production [superoxide anion (02) and hydroxyl radical (OH)] by
neutrophils activated via the interaction of antiGBM antibody, GBM
and complement were established. In these assays, DFX inhibited OH
production by immunologically—stimulated neutrophils (ISN) [nM
diphenollhr/106 cells, mean SaM, ISN/DFX = 8 2 compared with
ISN = 191 22, P <0.01] while production of O was not affected [nM
02/hr/106 cells, mean SEM, ISN/DFX = 29.1 4.3 compared with
ISN = 32.6 2.5, P> 0.05]. These studies demonstrate that the iron
chelator desferrioxamine can prevent neutrophil—dependent immune
renal injury by interfering with neutrophil function. Treatment with the
hydroxyl radical scavenger dimethylthiourea also significantly attenu-
ated renal injury in antiGBM-GN. Together, the in vivo and in vitro
data strongly suggest that neutrophil—dependent immunological renal
injury is mediated via hydroxyl radical production by activated neutro-
phils within glomeruli.
There is considerable evidence that toxic oxygen free—radi-
cals play a key role in the cellular damage caused by antibiotics
[1], radiation [2], xenobiotics [3], and phagocytic cells [4]. In
particular, in vitro studies have demonstrated that the activated
neutrophil polymorph generates a number of toxic oxygen
radicals including superoxide anion (02), hydrogen peroxide
(H202), and the hydroxyl radical (OH) [5, 6]. In vivo studies of
immune—complex—induced vasculitis and acute lung injury sug-
gest that oxygen radical production contributes significantly to
inflammatory injury in these neutrophil—dependent disease
models [7].
Although much attention has been focused on 02 and H202
production and the effects of scavengers of these radicals on
various disease states [7—10], it is unlikely that they themselves
mediate severe tissue injury, as they are poorly reactive in
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aqueous solution [11]. More recently it has been proposed that
OH radical formation is the ultimate mechanism of both 02
and H202 toxicity [11, 12].
Generation of the extremely reactive, tissue damaging OH
radical for 02 and H202 occurs via the Haber—Weiss reaction,
which requires a transition—metal ion catalyst [4]. Iron is the
most potent known metal catalyst for this reaction [131.
Desferrioxamine (DFX) is a potent iron chelator isolated
from Streptomyces Pilosus. It has been shown to both inhibit
the iron-catalyzed Haber—Weiss reaction, thus blocking OH
generation from 02 and H202 [14] and to be a potential
scavenger of preformed OH [15]. DFX has minimal toxicity in
vivo and is thus a suitable tool with which to study disease
processes thought to involve OH production.
The current study sought to determine the role of hydroxyl
radicals in the mediation of a neutrophil—dependent model
of immune renal injury. We first verified that a model of the
acute phase of anti-glomerular basement membrane, antibody—
induced glomerulonephritis (antiGBM-GN) in the rabbit was
neutrophil dependent by demonstrating that neutrophil deple-
tion totally prevented the increase in protein excretion seen
after antiGBM antibody administration to normal animals. The
effects of the OH radical inhibitor DFX on glomerular injury in
vivo, and on the production of O and OH by immunologically
activated neutrophils in vitro, have been assessed. The in vivo
effects of iron chelation on immune renal injury have been
compared with the effects of the hydroxyl scavengers
dimethylsulphoxide (DMSO) and dimethylthourea (DMTU)
[161. These studies complement an increasing body of evidence
suggesting that the iron catalyzed conversion of neutrophil
generated H202 and O2 to the hydroxyl radical (OH) is
important in acute tissue injury [11, 12, 17]. More specifically,
they demonstrate for the first time an important role for the OH
radical in the production of antibody—initiated immune renal
injury.
Methods
In vivo studies
Model of antiGBM-GN. All studies were performed in
outbred male rabbits (1.5 to 3.5 kg). Sheep anti-rabbit GBM
antibody was prepared by the repeated immunization of a sheep
with purified particulate rabbit GBM in Freunds complete
adjuvant as previously described [18]. The sheep serum was
extensively absorbed against rabbit serum, platelets, leuco-
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cytes, and red cells and administered as a globulin fraction.
Antibody was given intravenously at a dose which produced
renal binding of 93.8 7.6 .tg antibody per gram of kidney
cortex (,Ltg/g) (N = 12). Control animals (N = 14) were given an
equivalent quantity of a similarly prepared, non-immune sheep
serum. Neutrophil depletion (N 6) was achieved by admin-
istering nitrogen mustard (Boots, Nottingham, UK) intrave-
nously 72 hours prior to antibody administration at a dose of
1.75 mg/kg, a regimen shown previously to produce profound
neutropenia in rabbits [191. All animals were housed in meta-
bolic cages for the 24 hour period following globulin adminis-
tration.
Desferrioxamine treatment. Desferrioxamine mesylate
(Ciba—Geigy, Lane Cove, Australia) was dissolved in distilled
water at a final concentration of 100 mg/ml. Treated animals (N
= 18) received 0.3 to 30 mg/kg i.v. immediately prior to
antibody administration and then 300 mg/kg by deep intramus-
cular injection into two sites.
Iron—saturated desferrioxamine treatment. In some experi-
ments desferrioxamine mesylate, saturated with FeC13 as de-
scribed elsewhere [20], was substituted for unsaturated desfer-
rioxamine.
Dimethylthiourea treatment. 1,3 dimethyl-2-thiourea
(Aldrich Chemicals, Wisconsin, USA) was dissolved in distilled
water at a final concentration of 500 mg/mI. Treated animals (N
= 8) received 500 mg/kg i.p. immediately prior to and 12 hours
following antibody administration.
Dimethylsuiphoxide treatment. Dimethylsuiphoxide (Ajax
Chemicals, Sydney, Australia) was administered i.p. Treated
animals (N = 4) received 1.5 mI/kg immediately prior to and 12
hours following antibody administration.
Creatinine clearance. Creatinine concentrations were deter-
mined on plasma samples obtained at 12 hours and 24 hours
after antibody administration. Urine creatinine concentration
was measured on the collected 24 hour sample, and these
results used together with the 24 hour urine volume to estimate
the endogenous creatinine clearance rate.
Proteinuria. Urine protein concentrations were determined
using the Coomassie Brilliant Blue dye binding assay [211.
Complement estimations. CH50 assays, using the standard
techniques of Ward and Cochrane [221, were performed on
animals immediately prior to study (t0) and at 12 and 24 hours
after antibody administration.
Antibody binding studies. Specific antiGBM antibody binding
was assessed with trace labelled antibody using double isotope
techniques previously described [23].
Histology. Kidney tissues were placed in Bouins tissue
fixative and snap—frozen in liquid nitrogen. Sections for light
microscopy were cut and stained with hematoxylin, eosin, and
periodic acid schiff's reagent (PAS). Immunofluorescence sec-
tions were cut at 8 s and examined by direct immunofluores-
cence techniques for the presence of sheep IgG and rabbit C3
(Research Plus Laboratories, Bayonne, New Jersey, USA).
Glomerular neutrophil counts were performed on PAS stained
sections. A minimum of 20 equatorially—sectioned glomeruli
were assessed per rabbit, and the results were expressed as the
mean number of neutrophils per glomerular cross—section
(n/gcs).
In vitro studies
Neutrophil preparation. In all experiments outbred rabbits of
1.5 to 3.5 kg were used. Glycogen—induced peritoneal exudate
cells provided the source of neutrophils. Cells were washed
three times in 50 volumes of Hanks balanced salt solution
(HBSS) before being resuspended in HBSS containing twice the
normal glucose concentration and without the addition of
phenol red [24]. Cell suspensions were made to contain 106
neutrophils/ml.
Measurement of superoxide (02) production. Superoxide
generation was measured by the superoxide—dismutase—inhibi-
table reduction of ferricytochrome C according to Babior,
Kipnes and Curnutte [24]. Neutrophil reaction mixtures con-
taining ferricytochrome C and 3 x 106 cells were prepared in
triplicate in the presence and absence of superoxide dismutase
(Sigma Chemical Co., St. Louis, Missouri, USA). Internal
controls included samples with the addition of 25 ng phorbol
myristate acetate (PMA) (Sigma) and 100 d isotonic saline
solution. The immunologically—stimulated neutrophil (ISN)
specimens consisted of sheep anti-rabbit GBM antibody as a
globulin fraction (50 jsg) with collagenase—solubilized rabbit
GBM (CSGBM) [181 (50 g) and fresh normal rabbit serum (50
jd). Normal sheep globulin (50 JLg) with CSGBM (50 gig) and
fresh normal rabbit serum (50 1.d) constituted a further 'non-
immune' control. DFX was added to selected samples at a
concentration of up to 1 M. Samples had a final volume of 3.1
ml. After preparation all reaction mixtures were stored on ice.
Before incubation 1.5 ml of each reaction mixture was reserved
at 0°C for use as a blank. The remainder was incubated at 37°C
for 60 minutes, Reactions were terminated by placing the
vessels in melting ice. After centrifugation of blanks and
incubated mixtures at 15,000 g for 15 minutes at 4°C, SOD-
inhibitable cytochrome C reduction was determined by measur-
ing the absorbance of the supernatants at 550 nm. The E550 was
taken as 1.55 x 1O M1 cm.
Measurement of hydroxyl radical (OH) production. The
generation of OH was measured by the hydroxylation of
salicylic acid, using the techniques and conditions described by
Halliwell and Ahluwalia [251. Triplicate tubes containing 3 X
106 neutrophils were prepared. To each tube 7.5 sM salicylic
acid and 24.9 LM KI-12P04 were added and adjusted to pH 6.0
with KOH. Control preparations, immune—stimulated neutro-
phil preparations, non-immune stimulated and 1)FX treated
preparations were assembled as for the O2 studies. Samples
were incubated at 37°C under air for 60 minutes. The reaction
was stopped by adding 30 tl of concentrated HCI and the
products extracted into diethyl ether. The samples were then
processed to detect 0-dihydric phenols as described previously
[25].
Statistics. All data is expressed as mean SEM. The signif-
icance of differences between group data was determined using
Student's t-test for unpaired data.
Results
Model of antiGBM-GN
Control animals (N = 14) given normal sheep globulin had a
24 hour urine protein excretion of less than 30 mg/24 hrs (Table
1). CrCl in these animals was 2.7 0.5 mI/mm. CH5() at 24 hrs
Hydroxyl radical mediation of renal injury 815
Table 1. Neutrophil dependence of antiGBM-GN model
Parameter AntiGBM-GN
Neutrophil deplete
antiGBM-GN
N 12 6
AntiGBM antibody binding pg 93.8 7.6 105.4 4.5
antibody/g kidney cortex
24 hr protein excretion mg 271.5± 92.2 11.3 2.l
Circulating neutrophils n/mm3 4310 285 <150a
Glomerular neutrophils n/gcs 6.2 3.0 0.1 0.la
CH50 24 hr value expressed as 110.1± 10.2 98.2 5.7
percentage of value at to
GlomerularC3onlF +++ +++
0 to + + +
CrCl mI/mm 1.9 0.4 2.5 0.6
a P < 0.01 compared with antiGBM-GN
was 102.4 4.5% of the pre-injection value (t0); only 0.4 0.1
nlgcs were observed in histological sections.
Rabbits given antiGBM antibody (N = 12) developed heavy
proteinuria (24 hr protein excretion of 271.5 92.2 mg). The
CrCl of this group was decreased (1.9 0.4 mI/mm). The CR50
level at 24 hours was normal (10.1 10.2% of the value at t0).
Direct IF studies revealed a linear fluorescence pattern for
sheep IgG and rabbit C3 in all glomeruli. A diffuse proliferative
glomerulonephritis with significant neutrophil infiltration (6.2
3.1 n!gcs) was observed in all rabbits.
Nitrogen mustard—treated animals (N = 6) had quantities of
kidney fixed antibody (105.4 4.5 pgIg) comparable to the
antiGBM-GN group. These animals had no detectable circulat-
ing neutrophils at the time of antibody administration and at
sacrifice (<150 neutrophils/mm3). The increased protein excre-
tion seen after antibody administration in normal animals was
prevented by neutrophil depletion (11.3 2.1 mg/24 hr, P <
0.01). The CrC! in this group was normal (2.5 0.6 ml/min),
with a normal CR50 (at 24 hrs of 98.2 5.7% of value at t0).
Despite glomerular sheep IgG and rabbit C3 in quantities similar
to the antiGBM-GN group, there were no neutrophils in capil-
lary loops on light microscopy (0.1 0.1 n/gcs, P <0.01).
Effect of DFX in vivo
DFX treated animals (N = 18) had an antiGBM antibody
binding of 96.9 6.6 g/g KFA (Table 2). Animals given more
than 1 mg/kg i.v. (N = 15) had a 24 hour protein excretion
within the control range (16.2 2.9 mg) and a normal CrC1 (2.4
0.6 mllmin). The CH50 was normal at 24 hours, (104.5 8.4%
t0 value). Sheep IgG and rabbit complement were deposited in
quantities similar to the antiGBM-GN group on IF. The num-
bers of neutrophils in capillary loops was increased (4.7 2.1
n/gcs) and did not differ significantly from the antiGBM-GN
group.
Effect of non-saturated DFX in vivo
Iron saturated DFX (10 mg/kg i.v.) (N = 4) did not signifi-
cantly attenuate immune renal injury (protein excretion 166.5
121.1 mg/24 hrs; CrCI 1.8 0.3 mllmin).
Effect of DFX in vitro
O[ production. Unstimulated neutrophils produced no sig-
nificant O (1.38 0.19 nMO2/hr/106 cells) (Table 3). Stimu-
Table 2. Effects of DFX on antiGBM-GN in vivo
Parameter AntiGBM-GN
DFX +
AntiGBM-GN
AntiGBM antibody binding 93.8 7.6 96.9 6.6
,ag/g
24 hr protein excretion mg 271.5 92.2 16.2 2.9a
Circulating neutrophils 4310 285 4890 483
n/mm3
Glomerular neutrophils n/gcs 6.2 3.1 4.7 2.1
CH50 24 hr value expressed 110.1 10.2 104.5 8.4
as percentage of value
at to
Glomerular C3 on IF + + + + + +
0 to + + +
CrC1 mI/mm 1.9 0.4 2.4 0.6
a P < 0.01 compared with untreated antiGBM-GN
Table 3. Effects of DFX on oxygen radical production in vitro
Reaction mixture n
03 production
nMO2/ hr/JO6
cells
OH. production
nMdiphenol/hr/J0
cells
Neutrophils alone 8 1.4 0.2 4 3
Neutrophils + PMA (Sng/ml) 8 18.8 2.7 72 14
Neutrophils + 50 sg CSGBM
50g antiGBM 8 32.6 2.5 191 22a
50/11 serum
Neutrophils + 50g CSGBM
50g antiGBM 8 29.1 4.3 8 2
501.d serum
1 mM DFX
Neutrophils + 50sg CSGBM
50g NSG 8 7.8 1.3 13 4
50d serum
a P < 0.01
lation with PMA resulted in 02 production (18.79 2.65
nMO2/hr/106 cells). Immune (antiGBM-GBM-complement)
stimulated cells produced 32.61 2.52 nMO2/hr/l06 cells,
whereas the non-immune control (normal globulin-GBM-comp-
lement) produced only 7.75 1.30 nMO2/hr/106 cells. The
addition of DFX (1 mM) to the reaction mixtures did not alter
02 generation by immune stimulated neutrophils (29.08 4.32
nMO2/hr/106 cells). Increasing concentrations of DFX (up to
saturation, 1 M) had no effect on 02 generation.
OH production. Unstimulated neutrophils produced no sig-
nificant OH (4 3 nM/hr/106 cells). PMA stimulation of
neutrophils resulted in OR generation (72 14 nM/hr/l06 cells).
Immune stimulated neutrophils produced OH at the rate of 191
22 nM/hr/l06 cells. The normal globulin-GBM-complement
control produced 13 4 nM/hr/106 cells OH. The addition of
DFX at a dose shown not to effect 02 generation (1 mM)
abolished hydroxylation (95.8 1.0% inhibition).
Dose response relationships for DFX
In vivo (Fig. 1). The lowest i.v. dose of DFX tested (0.3
mg/kg) did not protect against renal injury. All higher doses
(that is, 1, 10 and 100 mg/kg) attenuated immune renal injury,
reducing protein excretion rates to control values.
In vitro (Fig. 2). The dose response curve for DFX and
generation of OH by immunologically stimulated neutrophils
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Table 4. Effects of hydroxyl radical scavengers in vivo
ISN SN SN SN SN SN
+
DFX DFX DFX DFX DFX
(2 LM) (5 M) (50 VIM) (200 M) (1 mM)
(as reflected by the hydroxylation of salicylate) illustrates that
significant inhibition of hydroxylation occurred with doses of
DFX in excess of 5 /.tM.
Effect of hydroxyl radical scavengers in vivo. DMTU treated
animals had 24 hour urinary protein excretion rates (32.7 3.6
mg) and creatinine clearances (2.3 0.5 mi/mm) which did not
differ from control values.
DMSO treated animals (N = 4) had 24 hour urinary protein
excretion rates (210.1 101.5 mg) and creatinine clearances
(1.7 0.4 mI/mm) which did not differ significantly from
untreated antiGBM-GN values. Higher doses of DMSO af-
forded some protection against the development of proteinuria,
but were lethal in the majority of animals studied (mortality
87.5%).
Discussion
The importance of oxygen free radicals as mediators of
inflammatory cell—induced injury is receiving wide recognition
[4, 7—12, 16]. The facility with which the hydroxyl radical can
interact with cell proteins, nucleic acids, and membrane lipids
under physiological conditions 141 make it a more likely medi-
ator of inflammatory cell—induced injury than either the super-
oxide anion or hydrogen peroxide, as both these moieties are
poorly reactive in aqueous solution [Ill. The discovery of the
essential role of iron in catalyzing OH radical generation from
02 and H202 1131 and the ability of iron chelators to inhibit
OH radical generation [14] led to speculation that chelators
such as desferrioxamine may protect against free—radical in-
duced injury [14, 17]. Clearcut evidence for the participation of
oxygen radicals, in particular the OH radical, is now available
for certain models of phagocyte dependent disease [11—13].
The current studies have shown that DFX is able to block
neutrophil—dependent immune renal injury in vivo and to inhibit
OH radical generation by immune stimulated neutrophils in
vitro, in vivo DFX treatment did not interfere with antibody
deposition or consequent glomerular complement activation.
DFX did not significantly effect renal hemodynamics as as-
sessed by its effects on glomerular filtration rate. DFX had no
effect on circulating neutrophil levels, and did not alter the
glomerular accumulation of neutrophils in response to glomer-
ular antibody deposition and complement activation. These
observations are supported by previous data showing that DFX
has no effect on neutrophil tissue localization in vivo or on in
vitro tests of neutrophil chemotaxis [121. However, despite
equivalent neutrophil infiltration of glomeruli, renal injury did
not occur with DFX treatment.
It is not possible to quantitate neutrophil OH production
directly in vivo, and there is also no ideal system for precisely
quantitating leucocyte hydroxyl radical production in vitro [4].
We established in vitro assay systems to provide indices of 02
and OH production by polymorphs to assess the effects of DFX
on immunologically stimulated neutrophils. in this system the
specific interaction of antiGBM antibody and GBM in the
presence of a complement source lead to enhanced oxygen
radical production. Using these in vitro systems, the current
study has demonstrated that DFX inhibits OH radical genera-
tion by immune stimulated neutrophils without effecting 02
production. Although not previously assessed, the dose of DFX
required to inhibit 01-I radical generation by ISN was similar to
that needed to inhibit enzymatically—stimulated OH radical
generation [14]. These results from in vitro assays strongly
suggest that the protection against neutrophil—dependent renal
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Fig. 1. DFX inhibition of abnormal proteinuria in vivo. DFX inhibited
neutrophil—dependent proteinuria when i.v. doses in excess of 0.3
mg/kg were administered.
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Fig. 2. DFX inhibition of OH production in vitro. DFX inhibited ISN
OH production in a dose related fashion.
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injury seen with DFX treatment is due to the inhibition of
hydroxyl radical generation by immunologically stimulated
neutrophils within glomeruli.
In a previous study, Rehan et al investigated the role of
oxygen radicals in the acute phase of a predominantly
neutrophil—dependent model of antiGBM-GN [261. This study
concluded that H202 production by activated neutrophils pro-
duced acute glomerular injury, as significant attenuation of
proteinuria occurred with treatment with the H202 inhibitor
catalase. However reduction in levels of H202 would also lead
directly to a decrease in OH radical generation by neutrophils
[4]. Rehan et al attempted inhibition of other oxy-radicals [02
with superoxide dismutase (SOD) and OH radical with
dimethyl sulphoxide (DMSO)] without producing significant
protective effects. In the current study DMSO provided no
protection against neutrophil—dependent glomerular injury,
while the more potent, non-toxic DMTU [16] was highly
effective in blocking renal injury.
A failure to show a protective effect using a particular oxygen
radical scavenger does not conclusively show that the radical of
interest is not involved in cellular injury [27]. There are a
number of potential mechanisms to account for the apparent
lack of effect of a particular scavenger. In vivo, interaction of
the free radical and the scavenger may be prevented by limited
delivery of the scavenging agents to the site of injury [27]. Both
in vivo and in vitro steric hindrance may prevent radical
scavenger interaction [27] as may electrostatic charge consid-
erations (such as, the negative charge on SOD limits its acces-
sibility to activated neutrophils [28]). In addition, a secondary
toxic radical may be formed after reaction of the oxygen radical
with the added scavenger. This is of particular importance with
DMSO, as the generation of toxic methyl radicals and methyl-
peroxy radicals after the reaction of OH radical and DMSO [29]
could mask any potential benefit of OH scavenging obtained
with the use of this agent. Thus, DMSO has significant limita-
tions in assessing OH radical—mediated injury in vivo.
The relative lack of systemic toxicity associated with DFX
and DMTU therapy facilitates in vivo experimentation. The
efficacy of DFX in blocking neutrophil—dependent renal injury
and neutrophil—hydroxyl radical production is illustrated in the
current study. This, together with the success of iron chelators
in attenuating another model of acute neutrophil—dependent
tissue injury [12], suggests that DFX may have a wide applica-
bility in the investigation and treatment of autoimmune diseases
involving phagocyte—generated hydroxyl radicals.
Reprint requests to Neil W. Boyce, M.D., Department of Medicine,
Prince Henry's Hospital, St. Kilda Road, Melbourne, Victoria, Aus-
tralia 3004.
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